Jennifer L Taylor-Cousar MD

  • Department of Medicine
Email
Taylor-CousarJ@NJHealth.org
Gender
Female

Board Certified

11/2008: ABP, Subspecialty in Pediatric Pulmonary
10/2006: ABIM, Subspecialty in Pulmonary Disease
8/2004: American Board of Internal Medicine
8/2002: American Board of Pediatrics

Research Interests

Cystic Fibrosis, innate immunity, CFTR function, clinical research

Service

Education & Training

Education

Duke University Medical Center (Durham, NC)
MD, 1998
Stanford University (Standford, CA)
BA, Human Biology, 1993

Residencies

Duke University Medical Center
Internal Medicine and Pediatrics, 1998-2002

Fellowships

Duke University Medical Center
Adult and Pediatric Pulmonary Medicine, 2002-2006

Awards & Recognition

2009: Cystic Fibrosis Research Institute Professional of the Year Award

2009: Selected participant, AAMC Early Career in Medicine Early Career Women Faculty Professional Development Seminar

2008: Clinical Trials Center New Investigator of the Year Award

2006: Duke University Pulmonary Fellowship Scientific Achievement Award

2005: 2nd Place, Fellows’ Clinical Research Presentations, Respiratory Disease Young Investigators Forum

2003: Cystic Fibrosis Foundation Clinical Fellowship

Recent or Important Publications

Taylor-Cousar JL, Zariwala MA, Burch LH, Pace RG, Drumm ML, Calloway H, Fan H, Weston BW, Wright FA, Knowles MR. Histo-blood Group Gene Polymorphisms as Potential Genetic Modifiers of Infection and Cystic Fibrosis Lung Disease Severity. PLoSOne. 2009
http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0004270

Taylor-Cousar JL. Hypoventilation in Cystic Fibrosis. Semin Respir and Crit Care Med. Semin Respir Crit Care Med. 2009;30(3):293-302.

Ornatowski W, Poschet JF, Perkett E, Taylor-Cousar JL and Deretic V. Hypersusceptibility to Pseudomonas aeruginosa Exotoxin A Due to Elevated Furin in Cystic Fibrosis Respiratory Epithelial Cells. J Clin Invest. 2007;117:3498-3506.

Poschet J, Timmins G, Taylor-Cousar JL, Ornatovski W, Fazio J, Perkett E, Wilson K, Yu HD, de Jonge HR and Deretic V. Pharmacological modulation of cGMP levels by Phosphodiesterase 5 Inhibitors as a Therapeutic Strategy for Treatment of Respiratory Pathology in Cystic Fibrosis. Am J Physiol Lung Cell Mol Physiol. 2007;293:L12-L19.

Taylor JL, and SM Palmer. A Critical Care Perspective on Immunotherapy in Lung Transplantation. Journal of Intensive Care Medicine. 2006; 21(6):327-344.

Curriculum Vitae

View Curriculum Vitae

Appointments

1-800-222-5864

Congratulations to Our 28 "Top Docs"

Twenty-eight physicians at National Jewish Health were named "Top Docs" in the annual ranking by 5280 magazine.
Learn more.

Personalized Medicine

National Jewish Health is at the forefront of a new era in healthcare - personalized medicine.

Our science is truly transforming the lives of millions. Learn more.

Media Center

In the Media Center, you can find National Jewish Health press releases, newsletters, annual reports and media contacts. Learn more.